WORLD RENOWNED
SCIENTIST · AUTHOR · ENTREPRENEUR
Providing The Blueprint to Solve America's Health Crisis
Discover the latest insights from Dr. Steven Quay as he continues to make waves in the field of biotechnology and medical research. Stay informed with Dr. Quay’s recent features and interviews, where he shares his expertise on topics ranging from breast cancer therapeutics to coronavirus research. Explore the cutting-edge developments and groundbreaking discoveries shaping the future of healthcare.
(Z)-Endoxifen Shown to Significantly Reduce Mammographic Breast Density, Potentially Paving the Way for Innovative Cancer Prevention Strategies
(Z)-Endoxifen Shown to Significantly Reduce Mammographic Breast Density, Potentially Paving the Way for Innovative Cancer Prevention Strategies
Dr. Steven Quay investigates COVID-19's origins, analyzing evidence that suggests SARS-CoV-2 may have resulted from a lab incident rather than natural transmission. Through statistical methods, Dr. Quay estimates a 98% probability of a lab origin, challenging popular theories about animal-to-human transmission and highlighting possible lab safety issues in Wuhan. In this video, he also emphasizes the importance of global safety regulations to prevent future pandemics. Watch to uncover key insights on COVID-19's origins and why lab safety matters for global health.
This video describes the clinical data from the Atossa Therapeutics press release of October 31, 2024 entitled, Atossa Therapeutics Releases Promising Preliminary Analysis Demonstrating (Z)-Endoxifen’s Potential to Rapidly Reduce Ki-67 and Tumor Volume in ER+/HER2- Breast Cancer
(Z)-Endoxifen Shown to Significantly Reduce Mammographic Breast Density, Potentially Paving the Way for Innovative Cancer Prevention Strategies
(Z)-Endoxifen Shown to Significantly Reduce Mammographic Breast Density, Potentially Paving the Way for Innovative Cancer Prevention Strategies
Dr. Steven Quay investigates COVID-19's origins, analyzing evidence that suggests SARS-CoV-2 may have resulted from a lab incident rather than natural transmission. Through statistical methods, Dr. Quay estimates a 98% probability of a lab origin, challenging popular theories about animal-to-human transmission and highlighting possible lab safety issues in Wuhan. In this video, he also emphasizes the importance of global safety regulations to prevent future pandemics. Watch to uncover key insights on COVID-19's origins and why lab safety matters for global health.
This video describes the clinical data from the Atossa Therapeutics press release of October 31, 2024 entitled, Atossa Therapeutics Releases Promising Preliminary Analysis Demonstrating (Z)-Endoxifen’s Potential to Rapidly Reduce Ki-67 and Tumor Volume in ER+/HER2- Breast Cancer
CORONAVIRUS SURVIVAL MANUAL
A Physician's Guide to Keep You and Your Family Healthy During the Coronavirus Pandemic and Beyond
Dive into the world of biotechnology and medical innovation with Dr. Steven Quay through engaging videos that offer valuable insights and expert commentary. Explore Dr. Quay’s latest video appearances, where he discusses groundbreaking research, pioneering treatments, and the latest advancements in healthcare. From discussions on breast cancer therapy to insights into coronavirus research, Dr. Quay’s videos provide a captivating glimpse into the future of medicine.
- 0:57
Elevator Medicine Jan 7 2025 H5N1 Bird Flu Death Update
102 views1 day ago - 0:57
Elevator Medicine Jan 7, 2025 First H5N1 Bird Flu Death in Louisiana
93 views1 day ago - 06:10
The Hidden Link Between Alcohol and Breast Cancer: Surgeon General's Warning Explained by Atossa CEO
91 views2 days ago - 10:27
Taiwan based scientist makes case for lab origin for COVID
264 views2 months ago - 04:33
iSPY Explainer Video
40,3K views2 months ago - 02:51
Lanzamiento de la Nueva Vacuna contra el COVID-19: Lo Que Necesitas Saber para el Otoño de 2024
40 views4 months ago
In the Tedx UofW talk, Steven Quay, M.D., Ph.D., and Atossa’s Chief Executive Officer outlines the journey of Atossa Therapeutics in identifying improved ways to identify women at high risk of breast cancer, using mammography to identify dense breast tissue. Dr. Quay also details his experience with triumph, failure, and perseverance while trying to prevent one of the world’s most common diseases: breast cancer. He emphasizes the need for unshaken efforts to solve such complex problems, and ways that he and his team are doing so in breast cancer research.
Stay updated on the latest media coverage featuring Dr. Steven Quay’s groundbreaking work in biotechnology and medical research. Explore recent news articles and press releases highlighting Dr. Quay’s contributions, from his insights on breast cancer therapeutics to his expertise in understanding infectious diseases like COVID-19. Delve into the forefront of healthcare innovation through valuable perspectives and advancements shaping the future of medicine.